Dr. Terry Rabinowitz, MD

Dr. Rabinowitz practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Rabinowitz's NPI, 1659388395, was assigned on August 2, 2006. Dr. Rabinowitz graduated from Case Western Reserve University School of Medicine in 1989. Dr. Rabinowitz holds Vermont license 0420009316.

Dr. Rabinowitz's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Rabinowitz's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Rabinowitz is also affiliated with Central Vermont Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Rabinowitz to 1 more dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rabinowitz practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rabinowitz's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dmand AI has Dr. Rabinowitz's licenses on file in 2 states: Vermont and New York.

CMS data shows 384 Medicare services from Dr. Rabinowitz across 5 procedure codes in 2024, for 122 Medicare patients. Medicare paid $30,560 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Rabinowitz in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have depression, and 75% have mood disorders. 51% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rabinowitz's median patient age at 48, with 62% women.

In 2024, Dr. Rabinowitz wrote 191 Medicare Part D claims for 29 patients. 91% of them were for generic drugs. CMS names the drug for 124 of them, across 6 drugs with 11 or more claims each, at $1,792 in total drug cost. In 2023, CMS named 104 claims across 5 drugs.

Dr. Rabinowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rabinowitz as offering telehealth.

Dmand AI links 28 papers to Dr. Rabinowitz, published from 2010 to 2025. 2015 was the busiest year, with 3. The most frequent topics are Telemedicine, Feasibility Studies and Referral and Consultation. Dr. Rabinowitz has published most often in Telemed J E Health. Dr. Rabinowitz's most frequent co-authors are James T. Boyd, MD, Katharine Lana Cheung, MD and Robert E. Gramling, MD.

Dr. Rabinowitz graduated from Case Western Reserve University School of Medicine in 1989.